Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alistair Chenery is active.

Publication


Featured researches published by Alistair Chenery.


Journal of Clinical Investigation | 2014

Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation

Frann Antignano; Kyle Burrows; Michael R. Hughes; Jonathan M. Han; Ken Kron; Nadia Penrod; Menno J. Oudhoff; Steven Kai Hao Wang; Paul H. Min; Matthew Gold; Alistair Chenery; Mitchell J.S. Braam; Thomas C. H. Fung; Fabio Rossi; Kelly M. McNagny; C.H. Arrowsmith; Mathieu Lupien; Megan K. Levings; Colby Zaph

Inflammatory bowel disease (IBD) pathogenesis is associated with dysregulated CD4⁺ Th cell responses, with intestinal homeostasis depending on the balance between IL-17-producing Th17 and Foxp3⁺ Tregs. Differentiation of naive T cells into Th17 and Treg subsets is associated with specific gene expression profiles; however, the contribution of epigenetic mechanisms to controlling Th17 and Treg differentiation remains unclear. Using a murine T cell transfer model of colitis, we found that T cell-intrinsic expression of the histone lysine methyltransferase G9A was required for development of pathogenic T cells and intestinal inflammation. G9A-mediated dimethylation of histone H3 lysine 9 (H3K9me2) restricted Th17 and Treg differentiation in vitro and in vivo. H3K9me2 was found at high levels in naive Th cells and was lost following Th cell activation. Loss of G9A in naive T cells was associated with increased chromatin accessibility and heightened sensitivity to TGF-β1. Pharmacological inhibition of G9A methyltransferase activity in WT T cells promoted Th17 and Treg differentiation. Our data indicate that G9A-dependent H3K9me2 is a homeostatic epigenetic checkpoint that regulates Th17 and Treg responses by limiting chromatin accessibility and TGF-β1 responsiveness, suggesting G9A as a therapeutic target for treating intestinal inflammation.


Journal of Experimental Medicine | 2016

G9a regulates group 2 innate lymphoid cell development by repressing the group 3 innate lymphoid cell program

Frann Antignano; Mitchell J.S. Braam; Michael R. Hughes; Alistair Chenery; Kyle Burrows; Matthew Gold; Menno J. Oudhoff; David Rattray; Timotheus Y.F. Halim; Alissa Cait; Fumio Takei; Fabio Rossi; Kelly M. McNagny; Colby Zaph

Antignano, Zaph, and collaborators show that the lysine methyltransferase G9a plays a critical role in determining the developmental programs of group 2 and 3 innate lymphoid cells.


PLOS ONE | 2013

The Retinoic Acid-Metabolizing Enzyme Cyp26b1 Regulates CD4 T Cell Differentiation and Function

Alistair Chenery; Kyle Burrows; Frann Antignano; T. Michael Underhill; Martin Petkovich; Colby Zaph

The vitamin A metabolite retinoic acid (RA) has potent immunomodulatory properties that affect T cell differentiation, migration and function. However, the precise role of RA metabolism in T cells remains unclear. Catabolism of RA is mediated by the Cyp26 family of cytochrome P450 oxidases. We examined the role of Cyp26b1, the T cell-specific family member, in CD4+ T cells. Mice with a conditional knockout of Cyp26b1 in T cells (Cyp26b1 −/− mice) displayed normal lymphoid development but showed an increased sensitivity to serum retinoids, which led to increased differentiation under both inducible regulatory T (iTreg) cell- and TH17 cell-polarizing conditions in vitro. Further, Cyp26b1 expression was differentially regulated in iTreg and TH17 cells. Transfer of naïve Cyp26b1 −/− CD4+ T cells into Rag1 −/− mice resulted in significantly reduced disease in a model of T cell-dependent colitis. Our results show that T cell-specific expression of Cyp26b1 is required for the development of T cell-mediated colitis and may be applicable to the development of therapeutics that target Cyp26b1 for the treatment of inflammatory bowel disease.


Journal of Leukocyte Biology | 2017

Early-life antibiotic treatment enhances the pathogenicity of CD4+ T cells during intestinal inflammation

Sebastian Scheer; Tiago Medina; Alex Murison; Matthew D. Taves; Frann Antignano; Alistair Chenery; Kiran K. Soma; Georgia Perona-Wright; Mathieu Lupien; C.H. Arrowsmith; Daniel De Carvalho; Colby Zaph

The incidence of inflammatory bowel diseases (IBDs) has steadily increased in recent decades—a phenomenon that cannot be explained by genetic mutations alone. Other factors, including the composition of the intestinal microbiome, are potentially important contributors to the increased occurrence of this group of diseases. Previous reports have shown a correlation between early‐life antibiotic (Abx) treatment and an increased incidence of IBD. In this report, we investigated the effects of early‐life Abx treatments on the pathogenicity of CD4+ T cells using an experimental T cell transfer model of IBD. Our results show that CD4+ T cells isolated from adult mice that had been treated with Abx during gestation and in early life induced a faster onset of IBD in Rag1‐deficient mice compared with CD4+ T cells of untreated mice. Ex vivo functional analyses of IBD‐inducing CD4+ T cells did not show significant differences in their immunologic potential ex vivo, despite their in vivo phenotype. However, genome‐wide gene‐expression analysis revealed that these cells displayed dysregulated expression of genes associated with cell‐cycle regulation, metabolism, and cellular stress. Analysis of Abx‐treated CD4+ T cell donors showed systemically elevated levels of the stress hormone corticosterone throughout life compared with untreated donors. The cohousing of Abx‐treated mice with untreated mice decreased serum corticosterone, and a consequent transfer of the cells from cohoused mice into Rag1‐deficient mice restored the onset and severity of disease to that of untreated animals. Thus, our results suggest that early‐life Abx treatment results in a stress response with high levels of corticosterone that influences CD4+ T cell function.


PLOS ONE | 2013

Requirement for Core 2 O-Glycans for Optimal Resistance to Helminth Infection

Sarah C. Mullaly; Menno J. Oudhoff; Paul H. Min; Kyle Burrows; Frann Antignano; David Rattray; Alistair Chenery; Kelly M. McNagny; Hermann J. Ziltener; Colby Zaph

The migration of lymphocytes to the small intestine is controlled by expression of the integrin α4β7 and the chemokine receptor CCR9. However, the molecules that specifically regulate migration to the large intestine remain unclear. Immunity to infection with the large intestinal helminth parasite Trichuris muris is dependent upon CD4+ T cells that migrate to the large intestine. We examine the role of specific chemokine receptors, adhesion molecules and glycosyltransferases in the development of protective immunity to Trichuris. Mice deficient in expression of the chemokine receptors CCR2 or CCR6 were resistant to infection with Trichuris. Similarly, loss of CD34, CD43, CD44 or PSGL-1 had no effect on resistance to infection. In contrast, simultaneous deletion of the Core2 β1,6-N-acetylglucosaminyltransferase (C2GnT) enzymes C2GnT1 and C2Gnt2 resulted in delayed expulsion of worms. These results suggest that C2GnT-dependent modifications may play a role in migration of protective immune cells to the large intestine.


Infection and Immunity | 2016

Low dose intestinal Trichuris muris infection alters the lung immune microenvironment and can suppress allergic airway inflammation

Alistair Chenery; Frann Antignano; Kyle Burrows; Sebastian Scheer; Georgia Perona-Wright; Colby Zaph

ABSTRACT Immunological cross talk between mucosal tissues such as the intestine and the lung is poorly defined during homeostasis and disease. Here, we show that a low-dose infection with the intestinally restricted helminth parasite Trichuris muris results in the production of Th1 cell-dependent gamma interferon (IFN-γ) and myeloid cell-derived interleukin-10 (IL-10) in the lung without causing overt airway pathology. This cross-mucosal immune response in the lung inhibits the development of papain-induced allergic airway inflammation, an innate cell-mediated type 2 airway inflammatory disease. Thus, we identify convergent and nonredundant roles of adaptive and innate immunity in mediating cross-mucosal suppression of type 2 airway inflammation during low-dose helminth-induced intestinal inflammation. These results provide further insight in identifying novel intersecting immune pathways elicited by gut-to-lung mucosal cross talk.


Mucosal Immunology | 2017

The transcriptional repressor HIC1 regulates intestinal immune homeostasis

Kyle Burrows; Frann Antignano; Michael Bramhall; Alistair Chenery; S Scheer; Vladimir Korinek; T. M. Underhill; Colby Zaph

The intestine is a unique immune environment that must respond to infectious organisms but remain tolerant to commensal microbes and food antigens. However, the molecular mechanisms that regulate immune cell function in the intestine remain unclear. Here we identify the POK/ZBTB family transcription factor hypermethylated in cancer 1 (HIC1, ZBTB29) as a central component of immunity and inflammation in the intestine. HIC1 is specifically expressed in immune cells in the intestinal lamina propria (LP) in the steady state and mice with a T-cell-specific deletion of HIC1 have reduced numbers of T cells in the LP. HIC1 expression is regulated by the Vitamin A metabolite retinoic acid, as mice raised on a Vitamin A-deficient diet lack HIC1-positive cells in the intestine. HIC1-deficient T cells overproduce IL-17A in vitro and in vivo, and fail to induce intestinal inflammation, identifying a critical role for HIC1 in the regulation of T-cell function in the intestinal microenvironment under both homeostatic and inflammatory conditions.


PLOS Pathogens | 2016

Intestinal Epithelial Cell-Intrinsic Deletion of Setd7 Identifies Role for Developmental Pathways in Immunity to Helminth Infection

Menno J. Oudhoff; Frann Antignano; Alistair Chenery; Kyle Burrows; Stephen A. Redpath; Mitchell J.S. Braam; Georgia Perona-Wright; Colby Zaph

The intestine is a common site for a variety of pathogenic infections. Helminth infections continue to be major causes of disease worldwide, and are a significant burden on health care systems. Lysine methyltransferases are part of a family of novel attractive targets for drug discovery. SETD7 is a member of the Suppressor of variegation 3-9-Enhancer of zeste-Trithorax (SET) domain-containing family of lysine methyltransferases, and has been shown to methylate and alter the function of a wide variety of proteins in vitro. A few of these putative methylation targets have been shown to be important in resistance against pathogens. We therefore sought to study the role of SETD7 during parasitic infections. We find that Setd7 -/- mice display increased resistance to infection with the helminth Trichuris muris but not Heligmosomoides polygyrus bakeri. Resistance to T. muris relies on an appropriate type 2 immune response that in turn prompts intestinal epithelial cells (IECs) to alter differentiation and proliferation kinetics. Here we show that SETD7 does not affect immune cell responses during infection. Instead, we found that IEC-specific deletion of Setd7 renders mice resistant to T. muris by controlling IEC turnover, an important aspect of anti-helminth immune responses. We further show that SETD7 controls IEC turnover by modulating developmental signaling pathways such as Hippo/YAP and Wnt/β-Catenin. We show that the Hippo pathway specifically is relevant during T. muris infection as verteporfin (a YAP inhibitor) treated mice became susceptible to T. muris. We conclude that SETD7 plays an important role in IEC biology during infection.


European Journal of Immunology | 2016

Chronic Trichuris muris infection alters hematopoiesis and causes IFN-γ-expressing T-cell accumulation in the mouse bone marrow

Alistair Chenery; Frann Antignano; Michael R. Hughes; Kyle Burrows; Kelly M. McNagny; Colby Zaph

Proinflammatory cytokines produced during immune responses to infectious stimuli are well‐characterized to have secondary effects on the function of hematopoietic progenitor cells in the BM. However, these effects on the BM are poorly characterized during chronic infection with intestinal helminth parasites. In this study, we use the Trichuris muris model of infection and show that Th1 cell‐associated, but not acute Th2 cell‐associated, responses to chronic T. muris infection cause a major, transient expansion of CD48−CD150− multipotent progenitor cells in the BM that is dependent on the presence of adaptive immune cells and IFN‐γ signaling. Chronic T. muris infection also broadly stimulated proliferation of BM progenitor cells including CD48−CD150+ hematopoietic stem cells. This shift in progenitor activity during chronic T. muris infection correlated with a functional increase in myeloid colony formation in vitro as well as neutrophilia in the BM and peripheral blood. In parallel, we observed an accumulation of CD4+, CD8+, and CD4−CD8− (double negative) T cells that expressed IFN‐γ, displaying activated and central memory‐type phenotypes in the bone marrow during chronic infection. Thus, these results demonstrate that Th1 cell‐driven responses in the intestine during chronic helminth infection potently influence upstream hematopoietic processes in the BM via IFN‐γ.


PLOS Pathogens | 2018

HIC1 links retinoic acid signalling to group 3 innate lymphoid cell-dependent regulation of intestinal immunity and homeostasis

Kyle Burrows; Frann Antignano; Alistair Chenery; Michael Bramhall; Vladimir Korinek; T. Michael Underhill; Colby Zaph

The intestinal immune system must be able to respond to a wide variety of infectious organisms while maintaining tolerance to non-pathogenic microbes and food antigens. The Vitamin A metabolite all-trans-retinoic acid (atRA) has been implicated in the regulation of this balance, partially by regulating innate lymphoid cell (ILC) responses in the intestine. However, the molecular mechanisms of atRA-dependent intestinal immunity and homeostasis remain elusive. Here we define a role for the transcriptional repressor Hypermethylated in cancer 1 (HIC1, ZBTB29) in the regulation of ILC responses in the intestine. Intestinal ILCs express HIC1 in a vitamin A-dependent manner. In the absence of HIC1, group 3 ILCs (ILC3s) that produce IL-22 are lost, resulting in increased susceptibility to infection with the bacterial pathogen Citrobacter rodentium. Thus, atRA-dependent expression of HIC1 in ILC3s regulates intestinal homeostasis and protective immunity.

Collaboration


Dive into the Alistair Chenery's collaboration.

Top Co-Authors

Avatar

Frann Antignano

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Kyle Burrows

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Kelly M. McNagny

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Menno J. Oudhoff

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Michael R. Hughes

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

David Rattray

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Georgia Perona-Wright

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Matthew Gold

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Mitchell J.S. Braam

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Fabio Rossi

University of British Columbia

View shared research outputs
Researchain Logo
Decentralizing Knowledge